Wasatch Advisors’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
RI
SAM
PCM
DCM
KCM
Wasatch Advisors's XGN Position: Q1 2025 in Review
Wasatch Advisors sold out of Exagen (XGN) in Q1 2025, closing a stake of 42,975 shares — an estimated $176K sold.
Wasatch Advisors first reported a position in XGN in Q3 2019 and held it in 22 quarters. The position peaked at $29.6M in Q1 2021. 38 funds tracked by Wall St. Rank hold XGN as of Q1 2025.
- Wasatch Advisors reported no remaining Exagen position as of Q1 2025 after selling out during the quarter.
- Wasatch Advisors sold 42,975 Exagen shares in Q1 2025, an estimated $176K.
- Wasatch Advisors first reported a position in Exagen in Q3 2019 and held it in 22 quarters.
- Wasatch Advisors's Exagen position peaked at $29.6M in Q1 2021.
- 38 funds tracked by Wall St. Rank held Exagen as of Q1 2025.
Based on Wasatch Advisors's 13F filing for Q1 2025, filed 15 May 2025.